Message to Action Duchenne families
Professor Kate Bushby updates results for Ataluren
BioMarin Announces Results for Phase 1 Clinical Study of BMN 195 for Duchenne Muscular Dystrophy BMN 195 Program Discontinued due to Pharmaceutical and Pharmacokinetic Challenges
Minister of State for Heatlh responds
Action Duchenne lobby is successful in gaining senior MPs backing
15 times champion jockey Tony McCoy takes part in race named after Action Duchenne
Following our lobby in June Paul Maynard MP raises questions about Standards of Care for Duchenne
Andrew Lansley's proposals in White Paper offer nothing for Duchenne patients
ITN news report of Action Duchenne Lobby June 16th 2010
Genetic medicines now a reality within foreseeable future for the rare genetic condition Duchenne Muscular Dystrophy thanks to discovery of the Human Genome
Second Early Day Motion since general election highlights Danish model of care and the need for all UK citizens to receive the same quality of care
Annamarie Dillon from Genzyme has sent Action Duchenne this recent update
Write to your MP today to follow up our brilliant Lobby of Parliament
The Age of the Genome
Broadened program marks key inflexion in Prosensa’s progress to a fully integrated specialty pharma company
Action Duchenne Lobby of Parliament June 16th
Dave Anderson MP sponsors EDM 206
Professors, Doctors and other Neuromuscular experts add their voice to call for further funding for best practice standards of care and research to find a cure for devastating condition
Parents and boys living with Duchenne march on Downing Street to raise awareness of heartbreaking disease and demand an increase in investment to end to postcode Lottery for medical care
Even a seed can make it to Parliament
Action Duchenne proud to support AVI as it announces first ever reported generation of greater than 50% dystrophin-positive fibres in a patient following systemic administration of Exon Skipping drugs in a DMD patient
Dont Cut our Care and New Medicines for Duchenne
Church supports local family living with Duchenne Muscular Dystrophy
PTC Therapeutics and PPMD have scheduled a call on May 27, 2010 at 5:00pm eastern. The call will include PTC President Stuart Peltz and Chief Medical Officer for the ataluren trial, Langdon Miller, MD.
Recent document published in Lancet Neurology details best practice for the treatment and care of Duchenne patients which can extend the length and quality of life of patients by 10 to 15 years
Trend for ‘pop-up’ restaurants fuels initiative from Action Duchenne where friends host paid for dinner parties
Carl collects his shiny award in front of proud family
Trend for ‘pop-up’ restaurants fuels initiative from Action Duchenne where friends host paid for dinner parties
Low dose of ataluren appears to show better results in 6 minute walk test
Manchester born, terminally ill fund raiser and tireless champion for Duchenne Muscular Dystrophy receives accolades
Do you have access to multi disciplinary expert medical care?
Prosensa’s second clinical candidate for treatment of Duchenne Muscular Dystrophy
Update from Genzyme
BBC Highlight Exhibition Launch
Join the Action Duchenne Community
Carl scoops top honours at Pride of Manchester Awards, beating Gary Barlow and Ryan Giggs
Action Duchenne launches nationwide appeal to get children to grow sunflowers to raise funds for charity
Carol Muskoron, Associate editor at www.allaboutyou.com, the online home of Good Housekeeping, House Beautiful, Prima, SHE, Country Living and Coast magazine reviews
Nick Catlin from Action Duchenne attended a conference call organised by PPMD in the USA with PTC therapuetics. Here are his notes from the meeting.
We have received this press release from PTC therapuetics concerning the Ataluren clinical trials
Karl Bettelheim reports on the international research conference in Italy in February
Charity launches second cook book after success of ‘Caledonian Kitchen’ with all proceeds to support research
Young Edward and his Mum Heidy are interviewed by GMTV
Manchester born, fund raiser and tireless champion for Duchenne Muscular Dystrophy in the running for Mancunion of the Year
Action Duchenne campaigner Carl Tilson, who is living with Duchenne Muscular Dystrophy, features in an article in the Sunday People supplement, Take it Easy
Leading pharmaceutical development company for serious diseases and medical conditions undertakes first steps in bringing new treatment for DMD to market
Leading pharmaceutical development company for serious diseases and medical conditions undertakes first steps in bringing new treatment for DMD to market
Positive RNA and Protein Signals in first cohorts (groups) analysed
First step is taken towards bringing an end to the current ‘postcode lottery’ of care for those living with Duchenne
Applications invited for comprehensive appraisals of new therapies by 15 December 2009
Recent successful trials of RNA-based drug provide foundations for new therapies for more patients with Duchenne Muscular Dystrophy
Professor Hanns Lochmüller, Professor Volker Straub, Professor Kate Bushby
Dr. Matthew Wood reports on recent developments in exon skipping trials from the Oligonucleotide Therapeutic Society meeting held in Fukuoka, Japan in November.
Successful fundraising continues to support funding for research into Duchenne Muscular Dystrophy
New role to help promote Internationally agreed Standards of Care for Duchenne Muscular Dystrophy
Record attendance at Duchenne Conference
Data shosw PMO well tolerated in penultimate dose cohort (10mg/kg)
Action Duchenne welcomes presentation of latest trial findings at annual conference
New Publication in Molecular Therapy Outlines Dramatic Effects in Animals Treated with Splice Switching PPMO, Demonstrates Promise for Treatment of Duchenne Muscular Dystrophy
Bicester Family organise fantastic charity auction event
from Science Business by Nuala Moran
Leiden and London, October 13 2009
Danny Smith Sams Dad reports on the latest AVI/MDEX trial
Action Duchenne sees positive step forward to paving way for individual genomic (designer) drugs to treat Duchenne
AVI-4658 Demonstrates Compelling Proof of Concept and Safety Profile for Pediatric Patients with DMD; Findings Support Progression to Current Systemic Use Trial
National charity for Duchenne Muscular Dystrophy to benefit from bank holiday family fun
Walton Report confirms ‘postcode lottery’ to life expectancy for patients living with muscular dystrophy
nominate a genius volunteer
Nick Catlin our CEO replies to Gillian Merron at the Department of Heatlh
Action Duchenne renews calls for ring fenced funding and more Centres of Excellence for the treatment of Duchenne Muscular Dystrophy in light of Government report
Action Duchenne provides $1.2m to support continuing development of drugs to treat Duchenne Muscular Dystrophy
Manchester terminally ill fund raiser bids for nomination to raise awareness of little known disease that is the biggest genetic childhood killer
Action Duchenne launches campaign to ask the Government to publish White paper
Single-gene disorders must not be left behind as new Genomic Medicines start to address more complex diseases
How to deal with Swine Flu outbreak
Parents and boys living with Duchenne march on Stormont to raise awareness of heartbreaking disease and demand an end to sub-standard care in Northern Ireland
Parents and boys living with Duchenne march on Downing Street to raise awareness of heartbreaking disease and demand an end to Postcode Lottery for medical care
Parents and boys living with Duchenne march on the Senedd to raise awareness of heartbreaking disease and demand an end to sub-standard medical care in Wales
Standards of Care Survey shows that over a third of all parents of children living with Duchenne feel that their child receives sub-standard medical care
Parents and boys living with Duchenne march on Holyrood to raise awareness of heartbreaking disease and demand an end to sub-standard care in Scotland
Famous musician becomes latest patron for Action Duchenne, the Charity that supports families and those living with Duchenne
Action Duchenne builds online interactive community to help and support families living with Duchenne Muscular Dystrophy
Lets get lobbying
from Günter Scheuerbrandt
Innovative photography project aims to show what living life with Duchenne is like by those whose lives are affected
Scottish recipe book featuring favourite recipes from over forty celebrities and chefs from forty top Scottish restaurants raises funds for Duchenne Muscular Dystrophy charity
Action Duchenne announces new patent registry with Duchenne Ireland
Muscular Dystrophy Charity holds 7th annual nationwide series of ‘Love Runs’ to raise money for research
Latest drug trial shows potential RNA therapeutic treatment for Duchenne Muscular Dystrophy, says Action Duchenne